Elisabet
Elisabet Alcocer Gomez, Sevilla ES
Patent application number | Description | Published |
---|---|---|
20150272911 | Use of AMPK Inducers and Metformin for the Treatment of Fibromyalgia - The present invention relates to the use of metformin, metformin derivatives, compounds containing metformin and compounds that induce the activation of AMPK phosphorylation for the treatment of fibromyalgia, reducing pain and depression, as well as dysfunctional biological parameters. | 10-01-2015 |
Elisabet Andersson, Stockholm SE
Patent application number | Description | Published |
---|---|---|
20080311091 | Engineered Dopamine Neurons and Uses Thereof - The invention relates to dopamine neuron determinants, the use of these determinants in differentiating cells to dopamine neurons, cells produced by the over-expression of these determinants, and uses of these cells. | 12-18-2008 |
Elisabet Ars Criach, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100086932 | BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD - The present invention relates to an in vitro non-invasive bladder cancer diagnosis and/or prognosis method based on the detection and quantification in bladder fluids of the gene expression of certain genes and/or combinations thereof acting as genetic markers of said disease. A bladder cancer diagnosis and/or prognosis kit based on the use of a set of probes suitable for the detection and quantification of the expression pattern of said genes is also contemplated. | 04-08-2010 |
Elisabet Borda Casas, Cardedeu ES
Patent application number | Description | Published |
---|---|---|
20110213020 | IMMUNOSTIMULANT COMPOSITIONS COMPRISING A NUCLEOBASE AND A POLYSACCHARIDE OBTAINABLE FROM FUNGI, YEAST OR BACTERIA - The present invention relates to compositions comprising nucleobases and/or sources of nucleobases and polysaccharides from extracts of fungi, yeasts or bacteria. Preferably, the compositions include Nucleoforce® or Nucleoforce® Dogs and AHCC®. Said compositions are useful in the treatment and prevention of immunosuppression, of the toxicity derived from chemotherapy or radiotherapy treatment, of diseases of the immune system, of cancer or an infection; and are also useful to stimulate the immune function in a mammal, including a human. | 09-01-2011 |
Elisabet De Los Pinos, Brookline, MA US
Patent application number | Description | Published |
---|---|---|
20120015899 | MODIFIED PLANT VIRUS PARTICLES AND USES THEREFOR - Aspects of the invention provide modified virus-like particles that are designed for therapeutic applications. In particular, aspects of the invention provide CCMV coat proteins that are modified to generate virus-like particles, including mosaic virus-like particles, that can package and/or deliver one or more diagnostic and/or therapeutic agents. The invention also provides methods for treating subjects with one or more modified virus-like particles. | 01-19-2012 |
20120171290 | HPV PARTICLES AND USES THEREOF - The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors. | 07-05-2012 |
20120207840 | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer - This invention relates to a transdermal delivery system for treating skin related diseases employing protein nanoparticles to deliver drugs to the keratinocytes and basal membrane cells for the treatment of non-melanoma skin cancer. The current invention presents an effective method for delivering small molecule nucleic acids to the epidermal cells. | 08-16-2012 |
20130012426 | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For the Treatment of Psoriasis - This invention relates to a transdermal delivery system for treating skin related diseases employing protein nanoparticles to deliver drugs to the keratinocytes and basal membrane cells for the treatment of Psoriasis. The current invention presents an effective method for delivering small molecule nucleic acids to the epidermal cells. | 01-10-2013 |
20130012450 | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Dermatology Related Genetic Diseases - This invention relates to a transdermal delivery system for treating skin related genetic diseases. More specifically, the present invention provides particles and methods for using pseudo-viruses, including those derived from the herpes and papillomaviruses, to deliver drugs to keratinocytes and basal membrane cells for the treatment of skin genetic disorders including Pachyonychia Congenita and Xeroderma Pigmentosum. | 01-10-2013 |
20130012566 | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia - This invention relates to a transdermal delivery system for treating skin related diseases employing papilloma-derived protein nanoparticles to deliver drugs to the keratinocytes and basal membrane cells for the treatment of alopecia. The current invention presents an effective method for delivering small molecule nucleic acids to the epidermal cells. | 01-10-2013 |
20130115247 | Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy - The invention is directed to novel compositions and methods utilizing virion derived protein nanoparticles for delivery of medical imaging agents and therapeutic agents for the diagnosis and treatment of malignant and systemic diseases. | 05-09-2013 |
20130116408 | Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy - The invention is directed to novel compositions and methods utilizing virion derived protein nanoparticles for delivery of medical imaging agents and therapeutic agents for the diagnosis and treatment of malignant and systemic diseases. The nanoparticles of the present invention are designed to deliver radioactive isotopes suitable for imaging a tumor and its metastases. Additionally, the nanoparticles may deliver a radioisotope that is suitable for treating a tumor and its metastases by alpha, beta or gamma radiation. Alternatively, the virion derived nanoparticles may deliver a treatment agent for cancer or a combination of a radioisotope and a cancer treatment agent. Additionally the virion derived nanoparticle may include delivery of a drug that enhances the immune system's recognition of the tumor. | 05-09-2013 |
20140377170 | VIRION-DERIVED NANOSPHERES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS TO CANCER CELLS - The invention relates to methods for producing papilloma-derived nanosphere particles that contain therapeutic, diagnostic, or other agents. The invention also provides nanosphere particle preparations that are useful for selectively delivering therapeutic, diagnostic, and/or other agents to cancer cells of subjects without eliciting a serotype-specific immunogenic response in the subjects. | 12-25-2014 |
Elisabet Gjernes, Nice FR
Patent application number | Description | Published |
---|---|---|
20150240235 | METHODS FOR PRODUCING A POPULATION OF PANCREATIC BETA-CELLS - The present invention relates to an in vitro or ex vivo method for producing a population of pancreatic beta-cells, comprising the step of inhibiting the expression or the activity of Arx in a population of pancreatic alpha-cells. The present invention also relates to method for inducing the conversion of pancreatic alpha-cells in pancreatic beta-cells in a patient in need thereof. | 08-27-2015 |
Elisabet Graupera, Sabadell ES
Patent application number | Description | Published |
---|---|---|
20100216926 | Use of Glycerol Acetals - Disclosed is the use of glycerol acetals as coalescent agents and/or solvents for making lacquers and paints. | 08-26-2010 |
20150065604 | Microcapsules For Paints And Lacquers - A paint or lacquer composition including microcapsules, which microcapsules are prepared according to the process including: (a) providing a mixture of an active and a polyvinylether; (b) polymerizing the mixture with maleic anhydride to form a copolymer matrix; and (c) cross-linking the copolymer matrix with a melamine-formalin resin to encapsulate the active in microcapsules with an average diameter of about 0.1 to about 25 μm for incorporating into a paint or a lacquer composition is provided. | 03-05-2015 |
Elisabet Gregori Puigjane, Alcobendas (madrid) ES
Patent application number | Description | Published |
---|---|---|
20130065966 | Compound Inhibiting Activation of the Enzyme ERK 1/2 To Be Used In The Treatment Of Neurodegenerative Illnesses - The present invention relates to a compound of formula (I) for use as a medicine, in particular for use in the treatment of diseases mediated by the actvation of the protein kinase Erk1/2, such as neurogenerative illnesses like Alzheimer's and related dementia, epilepsy, Parkinson's disease, Huntington's disease, or stroke, and likewise relates to the pharmaceutical compositions containing said compound. The compound of formula (I) effectively inhibits the activation of the enzyme Erk1/2 induced by the tissue plasminogen activator (TPA) and also effectively inhibits the apoptosis generated by the β-amyloid peptide. | 03-14-2013 |
Elisabet Helmerson, Billdal SE
Patent application number | Description | Published |
---|---|---|
20080311007 | PRESSURE EQUALIZING DEVICE, RECEPTACLE AND METHOD - Pressure equalizing device comprising a fluid container for attachment to a receptacle such as a vial to permit pressure equalization between the fluid container and the receptacle. The pressure equalizing device comprises a flow channel that is arranged to provide fluid communication into or out of the fluid container when the pressure equalizing device is attached to the receptacle. The pressure equalizing device also comprises a fluid inlet that contains a one-way valve that permits fluid to flow into the fluid container via said fluid inlet and that prevents fluid from flowing out of the fluid container via said fluid inlet and filter-receiving means that are arranged to permit fluid flowing into or out of the fluid container to be filtered when the filter-receiving means comprises a filter. | 12-18-2008 |
20080312634 | DEVICE FOR PROVIDING FLUID TO A RECEPTACLE - A device for providing sterilized or cleaned fluid to a receptacle and thereby facilitate conveyance of a substance out of the receptacle, comprising a connector and a container which form an integrated unit. The connector is provided with a first means for connection to a receptacle. Sterilized or cleaned fluid is transferred from the container to the receptacle. | 12-18-2008 |
20140116570 | Device For Providing Fluid To A Receptacle - A device for providing sterilized or cleaned fluid to a receptacle and thereby facilitating conveyance of a substance out of the receptacle, comprising a connector and a container which form an integrated unit. The connector is provided with a first means for connection to a receptacle. Sterilized or cleaned fluid is transferred from the container to the receptacle. | 05-01-2014 |
Elisabet Jerlhag, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20100093638 | TREAMENT FOR CHEMICAL SUBSTANCE ADDICTION - The present invention provides a method for the treatment of chemical substance abuse by selectively inhibiting ghrelin activity in humans comprising administering to a human in need thereof a therapeutically-effective amount of a ghrelin receptor ligand (GHS-RL). The ghrelin receptor ligand (GHS-RL) can be selected from the group consisting of a ghrelin receptor antagonist (GHS-RA), a ghrelin receptor inverse agonist (GHS-RIA), and a ghrelin receptor partial agonist (GHS-RPA). More specifically, the invention provides a method for treating alcohol related disorders in humans comprising administering to a human in need thereof a therapeutically-effective amount of a compound which is a ghrelin receptor ligand (GHS-RL), such as a ghrelin receptor antagonist (GHS-RA), a ghrelin receptor inverse agonist (GHS-RIA) and a ghrelin receptor partial agonist (GHS-RPA). | 04-15-2010 |
Elisabet Monita Castro US
Patent application number | Description | Published |
---|---|---|
20090326953 | Method of accessing cultural resources or digital contents, such as text, video, audio and web pages by voice recognition with any type of programmable device without the use of the hands or any physical apparatus. - The use of voice as a means of communication with a computer or programmable device ( | 12-31-2009 |
Elisabet Moragas Arjant, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20130316939 | DILUTABLE SURFACTANT COMPOSITION - Disclosed are aqueous, concentrated dilutable liquid cleaning compositions comprising one or more anionic surfactants, one or more non-ionic surfactants, and an electrolyte, preferably in combination with one or more amphoteric surfactants, having a total active matter higher than 45 wt % based on the sum of the surfactants above that exhibit a controllable viscosity profile that is satisfactory to the consumer while being easy to dilute, providing fast enough a diluted, a medium diluted or a highly diluted cleaning composition. | 11-28-2013 |
Elisabet Ortiz Tudela, Murcia ES
Patent application number | Description | Published |
---|---|---|
20140187871 | DEVICE WHICH COMPRISES A PHYSICAL ACTIVITY AND POSITION SENSOR, A PERIPHERAL TEMPERATURE SENSOR AND A LIGHT SENSOR FOR PROVIDING INFORMATION RELATING TO THE STATE OF THE CIRCADIAN SYSTEM - The invention is a device consisting of at least one body position and activity sensor, at least one peripheral temperature sensor and at least one light sensor, configured to provide information on the circadian system status and the sleep-wake status of an individual based on the data obtained from said sensors. It can be placed on the wrist of the subject, or on the subject's arm. The device may also include a blood pressure sensor. This device may be used in general studies of the human circadian system and, more specifically, for the study of sleep-wake and blood pressure rhythms. | 07-03-2014 |
Elisabet Viayna Gaza, Alella ES
Patent application number | Description | Published |
---|---|---|
20150099776 | Beta-Amyloid-Directed Multitarget Compounds For The Treatment Of Alzheimer's Disease - The compounds of formula (I), or its pharmaceutically acceptable salts, or any stereoisomer or mixture thereof, wherein: R | 04-09-2015 |
Elisabet Wagner, Bietigheim-Bissingen DE
Patent application number | Description | Published |
---|---|---|
20140360175 | Nozzle Arrangement and Motor Vehicle Drive Train - Nozzle arrangement for fluid applications, in particular for a hydraulic circuit of a motor vehicle drive train. A nozzle body has a first longitudinal end and a second longitudinal end. The nozzle body has a first longitudinal section having a cylindrical outer circumference, which has a first outside diameter. The nozzle body has a blind hole starting from the first longitudinal end. In the region of the second longitudinal end, the nozzle body has a second longitudinal section having a second outside diameter, which is smaller than the first outside diameter. A third longitudinal section is formed between the first longitudinal section and the second longitudinal section. A substantially radially aligned nozzle bore connects the outer circumference of the third longitudinal section to the blind hole. The outer circumference of the first longitudinal section is designed as a press-fitting surface, allowing the nozzle body to be pressed into a bore and allowing the second longitudinal section to form an annular gap with an inner circumference of the bore. | 12-11-2014 |
Elisabet Wallgard, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20090036362 | Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof - The present invention relates to polynucleotides and proteins associated with vasculogenesis- and angiogenesis-related disorders. The invention further relates to methods for the identification of compounds that modulate the expression of angiogenesis-related genes and gene products and to using such compounds as therapeutic agents in the treatment of angiogenesis-related disorders. The invention also relates to methods for the diagnostic evaluation, genetic testing and prognosis of angiogenesis-related disorders, and to methods and compositions for the treatment these disorders. | 02-05-2009 |
Elisabet Wallgard, Huskvarna SE
Patent application number | Description | Published |
---|---|---|
20090209473 | Componds and methods for pormoting angiogenesis - Angiogenesis may be initiated or increased through the use of gamma-secretase inhibitors. The gamma-secretase inhibitor can be a dipeptide class, sulfonamide class, transition state mimic class, benzodiazepine class, or benzocaprolactam class gamma secretase inhibitor. Methods for initiating and increasing angiogenesis are used for disease prevention and treatment as well as for generating research models. | 08-20-2009 |